Início › Câncer de Cólon › Tennessee › Nashville
Ensaios clínicos de Câncer de Cólon em Nashville, TN
16 estudos para Câncer de Cólon estão buscando participantes em locais em Nashville e arredores (num raio de aproximadamente 30 milhas). Abra um estudo para ver quem pode participar e como contatar a equipe.
Texto oficial do estudo (Inglês)
Recrutando participantes para um estudo? Destaque-o no topo desta página — $99 por 30 dias →
A Study of PHN-012 in Patients With Advanced Solid Tumors
RecrutandoFase 1
- PHN-012-001 Site, Nashville
Symbiotic-GI-03: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Metastatic Colorectal Cancer
RecrutandoFase 3
- Henry-Joyce Cancer Clinic, Nashville
Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors
RecrutandoFase 1/2
- Sarah Cannon Research Institue, Nashville
A First-in-Human Trial of BLU-924 (SAR449336) in Advanced Solid Tumors Harboring KRAS Mutations
RecrutandoFase 1/2
- Tennessee Oncology, PLLC, Nashville
A Study to Investigate the Safety and Preliminary Efficacy of GSK5460025 Alone or in Combination With Other Anti-cancer Agents in Participants With Solid Tumors
RecrutandoFase 1/2
- GSK Investigational Site, Nashville
Colon Adjuvant Chemotherapy Based on Evaluation of Residual Disease
RecrutandoFase 2/3
- Vanderbilt University/Ingram Cancer Center, Nashville
Study of XmAb®819 in Subjects With Advanced Clear Cell Renal Cell Carcinoma
RecrutandoFase 1
- Xencor Investigative Site, Nashville
A Trial of RSC-1255 for Treatment of Patients With Advanced Malignancies
RecrutandoFase 1
- Sarah Cannon, SCRI Oncology Partners, Nashville
A Study to Evaluate the Safety and Efficacy of Mesothelin-Targeting Logic-gated CAR T, in Participants With Solid Tumors That Express MSLN and Have Lost HLA-A*02 Expression
RecrutandoFase 1/2
- Vanderbilt University Medical Center, Nashville
A Study of Fruquintinib Plus FOLFIRI as Second-Line Treatment for Participants With Metastatic Colorectal Cancer (FRUITFUL)
RecrutandoFase 2
- SCRI Oncology Partners, Nashville
A Study to Learn About Study Medicine ALTA3263 in Adults With Advanced Solid Tumors With KRAS Mutations
RecrutandoFase 1
- Research Site, Nashville
Study of RMC-9805 in Participants With KRAS G12D-Mutant Solid Tumors
RecrutandoFase 1
- Sarah Cannon Research Institute, Nashville
Study of RMC-6236 in Patients With Advanced Solid Tumors Harboring Specific Mutations in RAS
RecrutandoFase 1/2
- Sarah Cannon Research Institute, Nashville
Dose Escalation and Dose Expansion Study of MDX2001 in Patients With Advanced Solid Tumors
RecrutandoFase 1/2
- Sarah Cannon Research Institute, Nashville
Gastrointestinal Biomarkers in Tissue and Biological Fluid Samples From Colorectal Cancer Patients
RecrutandoEstudo observacional
- Veterans Affairs Medical Center - Nashville, Nashville
- Vanderbilt-Ingram Cancer Center, Nashville
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
RecrutandoEstudo observacional
- Massive Bio SYNERGY-AI site, Nashville
Ensaios de Câncer de Cólon em outras cidades
- Boston, MA22 estudos
- New York City, NY22 estudos
- Houston, TX20 estudos
- Los Angeles, CA16 estudos
- St. Louis, MO15 estudos
- Arlington, VA15 estudos
- Chicago, IL14 estudos
- San Antonio, TX14 estudos
- Baldwin Park, CA14 estudos
- Baltimore, MD13 estudos
- Tampa, FL13 estudos
- Washington, DC12 estudos
Outros estudos em Nashville
- Câncer de Pulmão de Não Pequenas Células97 estudos
- Câncer de Mama81 estudos
- Câncer Metastático70 estudos
- Câncer Colorretal69 estudos
- Câncer (todos os tipos)65 estudos
- Câncer de Ovário49 estudos
- Câncer de Próstata43 estudos
- Câncer de Pulmão40 estudos
- Carcinoma de Células Escamosas de Cabeça e Pescoço39 estudos
- Câncer de Pâncreas39 estudos
- Câncer Endometrial38 estudos
- Melanoma33 estudos
Fonte: ClinicalTrials.gov, dados obtidos em 6 de out. de 2026. Cada estudo define seus próprios critérios de elegibilidade; a equipe do estudo decide quem pode participar.